SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cells
Christiane Kuempers, Karina Stein, Doerte Nitschkowski…·Torsten Goldmann
Author
Universität UlmORCID 0000-0003-3539-2326Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Christiane Kuempers, Karina Stein, Doerte Nitschkowski…·Torsten Goldmann
T. T. Chandrasekaran, Michel Choudalakis, Alexander Bröhm…·Albert Jeltsch
This study shows that H3K14 acetylation directs SETDB1 activity via its Triple Tudor Domain, enabling H3K9 methylation and heterochromatin formation.
Lauri A. Aaltonen, Federico Abascal, Adam A. Abeshouse…·Johann Sebastian De Bono
This study identifies germline genetic variants influencing somatic mutation patterns in 2,642 cancer genomes across 39 cancer types.
Yuan Yuan, Young Seok Ju, Young-Wook Kim…·Mario Berríos
This study characterizes mitochondrial genomes in 2,700 cancer patients across 37 types using whole-genome sequencing and RNA-seq, revealing mutational patterns, truncating mutations, and nuclear transfer of mitochondrial DNA.
Pay Gießelmann, Björn Brändl, Etienne Raimondeau…·Franz-Josef Müller
This paper develops a Cas12a-based enrichment strategy and algorithm for nanopore sequencing to quantify repeat expansions and their methylation status.